|

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

RECRUITINGN/ASponsored by Dana-Farber Cancer Institute
Actively Recruiting
PhaseN/A
SponsorDana-Farber Cancer Institute
Started2023-10-16
Est. completion2026-12-31
Eligibility
Age12 Years – 25 Years
Healthy vol.Accepted
Locations2 sites

Summary

The goal of this study is to find the best way to help participants and families manage the stress of facing a serious illness and be better able to "bounce back" or be resilient after a difficult situation. Participants will take part in the "Promoting Resilience in Stress Management" PRISM program, which is designed to provide skills to change or improve the impact of stress in everyday life. The name of the intervention used in this research study is: -PRISM (a mobile app program comprised of 6 sessions of skills-based, manualized resilience education)

Eligibility

Age: 12 Years – 25 YearsHealthy volunteers accepted
Participants that have completed their main cancer-directed therapy at one of the study sites affiliated centers who meet all the eligibility criteria will be eligible for participation in this study.

Inclusion Criteria:

* All genders ≥ 12 and ≤ 25 years of age at baseline
* Participant is able to speak English or Spanish language (for PRISM sessions)
* Participant is able to read English or Spanish language (for completion of surveys)
* Participant is cognitively able to participate in PRISM sessions and complete written questionnaires and surveys, as judged by the site investigator

Conditions3

AnxietyCancerStress

Locations2 sites

Boston Children's Hospital
Boston, Massachusetts, 02215
Abby Rosenberg, MD206-987-6892abbyr_rosenberg@dfci.harvard.edu
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
Abby Rosenberg, MD206-987-6892abbyr_rosenberg@dfci.harvard.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.